Initiating Lantus® is a long-acting Insulin glargine, that offers many advantages, is as simple as 1, 2, 3. The Lantus® insulin pen can help manage blood sugar levels with just one prick a day and delivers the precise dose. As a result, quality of life is enhanced. A daily insulin dose of 0.2 IU/kg is sufficient to be supplied to patients in order to attain the required fasting plasma glucose levels; for example, 15 IU are enough for a patient weighing 75 kg. Insulin titration can be challenging for many patients and primary care providers who are involved in the treatment of patients with diabetes. Since Lantus® only requires titration every three days, the risk of hypoglycemia is decreased by more than 50%.
You are now being redirected to a third-party website.
Sanofi does not endorse or approve the content, products, services or opinions on the third-party website. Sanofi shall not be responsible or in any way liable for any injury or damage to any persons in view of any reliance placed on or action taken basis of the information on the third party website or any errors, omissions or inaccuracies and/or incompleteness of the information on the third party website.
Right answer: Both A and B. As per Diabetic & Ramadan guidelines, T2DM patients can safely continue glargine U-100 once daily at a reduced dose of 15 - 30% at Iftar1,2. Insulin glargine U-100 is safe to be used during Ramadan with no significant increase in hypoglycaemia3. One-on-one dietary educational session can also reduce the number of adverse events of fasting1.
.jpg/jcr:content/image%20(14).jpg)
